The development of a novel method to attenuate bacterial virulence is reported, which is based upon the use of designed transition-state analogues to select human catalytic antibodies capable of degrading bacterial quorum-sensing molecules.
No takes yet. Share an insight, caveat, or question.
Kapadnis et al. (2008) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: